Wan-Yee Tang

Wan-Yee Tang

Auto-generated profile, based on publicly available information

Wan-Yee Tang

Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, 130 De Soto St, Pittsburgh, 15261, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SHShuk-Mei Ho
Shuk-Mei Ho
WTWan-Yee Tang
Wan-Yee Tang
JFJessica Belmonte de Frausto
Jessica Belmonte de Frausto
GPGail Prins
Gail Prins
Early developmental perturbations have been linked to adult-onset prostate pathology, including excessive exposure to estrogenic compounds; however, the molecular basis for this imprinting event is not known. An important and controversial health concern is whether low-dose exposures to hormonally active environmental estrogens, such as bisphenol A, can promote human diseases, including prostate cancer. Here, we show that transient developmental exposure of rats to low, environmentally relevant doses of bisphenol A or estradiol increases prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis. We found permanent alterations in the DNA methylation patterns of multiple cell signaling genes, suggesting an epigenetic basis for estrogen imprinting. For phosphodiesterase type 4 variant 4 (PDE4D4), an enzyme responsible for cyclic AMP breakdown, a specific methylation cluster was identified in the 5′-flanking CpG island that was gradually hypermethylated with aging in normal prostates, resulting in loss of gene expression. Early and prolonged hypomethylation at this site following neonatal estradiol or bisphenol A exposure resulted in continued, elevated PDE4D4 expression. Cell line studies confirmed that site-specific methylation is involved in transcriptional silencing of the PDE4D4 gene and showed hypomethylation of this gene in prostate cancer cells. Importantly, the PDE4D4 alterations in the estrogen-exposed prostates were distinguishable before histopathologic changes of the gland, making PDE4D4 a candidate molecular marker for prostate cancer risk assessment as a result of endocrine disruptors. In total, these findings indicate that low-dose exposures to ubiquitous environmental estrogens affect the prostate epigenome during development and, in so doing, promote prostate disease with aging. (Cancer Res 2006; 66(11): 5624-32)

16 February 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FPFrederica Perera
Frederica Perera
WTWan-Yee Tang
Wan-Yee Tang
JHJulie Herbstman
Julie Herbstman
DTDeliang Tang
Deliang Tang
LLLinda Levin
Linda Levin
SHShuk-Mei Ho
Shuk-Mei Ho
In a longitudinal cohort of ∼700 children in New York City, the prevalence of asthma (>25%) is among the highest in the US. This high risk may in part be caused by transplacental exposure to traffic-related polycyclic aromatic hydrocarbons (PAHs) but biomarkers informative of PAH-asthma relationships is lacking. We here hypothesized that epigenetic marks associated with transplacental PAH exposure and/or childhood asthma risk could be identified in fetal tissues. Mothers completed personal prenatal air monitoring for PAH exposure determination. Methylation sensitive restriction fingerprinting was used to analyze umbilical cord white blood cell (UCWBC) DNA of 20 cohort children. Over 30 DNA sequences were identified whose methylation status was dependent on the level of maternal PAH exposure. Six sequences were found to be homologous to known genes having one or more 5′-CpG island(s) (5′-CGI). Of these, acyl-CoA synthetase long-chain family member 3 (ACSL3) exhibited the highest concordance between the extent of methylation of its 5′-CGI in UCWBCs and the level of gene expression in matched fetal placental tissues in the initial 20 cohort children. ACSL3 was therefore chosen for further investigation in a larger sample of 56 cohort children. Methylation of the ACSL3 5′-CGI was found to be significantly associated with maternal airborne PAH exposure exceeding 2.41 ng/m3 (OR = 13.8; p<0.001; sensitivity = 75%; specificity = 82%) and with a parental report of asthma symptoms in children prior to age 5 (OR = 3.9; p<0.05). Thus, if validated, methylated ACSL3 5′CGI in UCWBC DNA may be a surrogate endpoint for transplacental PAH exposure and/or a potential biomarker for environmentally-related asthma. This exploratory report provides a new blueprint for the discovery of epigenetic biomarkers relevant to other exposure assessments and/or investigations of exposure-disease relationships in birth cohorts. The results support the emerging theory of early origins of later life disease development.

19 November 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AFAshley L. Fink
Ashley L. Fink
KEKyrra Engle
Kyrra Engle
RURebecca L. Ursin
Rebecca L. Ursin
WTWan-Yee Tang
Wan-Yee Tang
SKSabra L. Klein
Sabra L. Klein
Significance: Biological sex is typically not considered in the evaluation of vaccine responses and protection against infection. We show that female mice mount greater humoral and cell-mediated immune responses to influenza infection and vaccination than males. Females can rely solely on antibody for protection following vaccination, which is associated with greater expression of toll-like receptor 7 ( Tlr7 ) caused by epigenetic mechanisms in B cells from females. Deletion of Tlr7 reduces sex differences in vaccine-induced antibody responses and protection. The increased expression of Tlr7 in B cells contributes to greater antibody production in females than males, which has a functional advantage for vaccine efficacy.

20 July 2007 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
WTWan-Yee Tang
Wan-Yee Tang
SHShuk-Mei Ho
Shuk-Mei Ho

29 April 2015 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
ARAdrian Ruiz-Hernandez
Adrian Ruiz-Hernandez
CKChin-Chi Kuo
Chin-Chi Kuo
PRPilar Rentero-Garrido
Pilar Rentero-Garrido
WTWan-Yee Tang
Wan-Yee Tang
JRJosep Redon
Josep Redon
MTMaria Tellez-Plaza
Maria Tellez-Plaza
Current evidence supports the notion that environmental exposures are associated with DNA-methylation and expression changes that can impact human health. Our objective was to conduct a systematic review of epidemiologic studies evaluating the association between environmental chemicals with DNA methylation levels in adults. After excluding arsenic, recently evaluated in a systematic review, we identified a total of 17 articles (6 on cadmium, 4 on lead, 2 on mercury, 1 on nickel, 1 on antimony, 1 on tungsten, 5 on persistent organic pollutants and perfluorinated compounds, 1 on bisphenol A, and 3 on polycyclic aromatic hydrocarbons). The selected articles reported quantitative methods to determine DNA methylation including immunocolorimetric assays for total content of genomic DNA methylation, and microarray technologies, methylation-specific quantitative PCR, Luminometric Methylation Assay (LUMA), and bisulfite pyrosequencing for DNA methylation content of genomic sites such as gene promoters, LINE-1, Alu elements, and others. Considering consistency, temporality, strength, dose-response relationship, and biological plausibility, we concluded that the current evidence is not sufficient to provide inference because differences across studies and limited samples sizes make it difficult to compare across studies and to evaluate sources of heterogeneity. Important questions for future research include the need for larger and longitudinal studies, the validation of findings, and the systematic evaluation of the dose-response relationships. Future studies should also consider the evaluation of epigenetic marks recently in the research spotlight such as DNA hydroxymethylation and the role of underlying genetic variants.

22 January 2008 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PDF file
GPGail Prins
Gail Prins
WTWan‐Yee Tang
Wan‐Yee Tang
JBJessica Belmonte
Jessica Belmonte
SHShuk‐Mei Ho
Shuk‐Mei Ho
Abstract:  An important and controversial health concern is whether low‐dose exposures to hormonally active environmental oestrogens such as bisphenol A can promote human diseases including prostate cancer. Our studies in rats have shown that pharmacological doses of oestradiol administered during the critical window of prostate development result in marked prostate pathology in adulthood that progress to neoplastic lesions with ageing. Our recent studies have also demonstrated that transient developmental exposure of rats to low, environmentally relevant doses of bisphenol A or oestradiol increases prostate gland susceptibility to adult‐onset precancerous lesions and hormonal carcinogenesis. These findings indicate that a wide range of oestrogenic exposures during development can predispose to prostatic neoplasia that suggests a potential developmental basis for this adult disease. To identify a molecular basis for oestrogen imprinting, we screened for DNA methylation changes over time in the exposed prostate glands. We found permanent alterations in DNA methylation patterns of multiple cell signalling genes suggesting an epigenetic mechanism of action. For phosphodiesterase type 4 variant 4 (PDE4D4), an enzyme responsible for intracellular cyclic adenosine monophosphate breakdown, a specific methylation cluster was identified in the 5′‐flanking CpG island that was gradually hypermethylated with ageing in normal prostates resulting in loss of gene expression. However, in prostates exposed to neonatal oestradiol or bisphenol A, this region became hypomethylated with ageing resulting in persistent and elevated PDE4D4 expression. In total, these findings indicate that low‐dose exposures to ubiquitous environmental oestrogens impact the prostate epigenome during development and in so doing, promote prostate disease with ageing.